Alliance Global Partners Starts Adial Pharmaceuticals Inc (ADIL) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ADIL Hot Sheet
Price: $5.05 --0%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 22 | New: 0
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 22 | New: 0
Join SI Premium – FREE
Alliance Global Partners analyst James Molloy initiates coverage on Adial Pharmaceuticals Inc (NASDAQ: ADIL) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Adial Pharmaceuticals Inc click here. For more ratings news on Adial Pharmaceuticals Inc click here.
Shares of Adial Pharmaceuticals Inc closed at $3.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Telsey Downgrades Floor & Decor Holdings (FND) to Market Perform
- SanDisk (SNDK) PT Lowered to $2,000 at BofA Securities
- Merck (MRK) PT Raised to $165 at BofA Securities
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
